Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02
Clinical trial NCT04167696 · RECRUITING
Trial details
- NCT number
- NCT04167696
- Sponsor
- Celyad Oncology SA
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-25
- Primary completion
- 2021-12-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.